Renz P, Wurm R, Hörig J
Z Naturforsch C Biosci. 1977 Jul-Aug;32(7-8):523-7. doi: 10.1515/znc-1977-7-808.
Riboflavin, the biosynthetic precursor of the 5,6-dimethylbenzimidazole moiety of vitamin B12, is transformed non-enzymatically into 5,6-dimethylbenzimidazole in small yield on treatment with 1 N or 5 N NaOH at 100 degrees C. Besides 5,6-dimethylbenzimidazole 1,2-diamino-4,5-dimethylbenzene, 1,2-dihydro-6,7-dimethyl-2-keto-1-D-ribityl-3-quinoxaline carboxylic acid and N-1-D-ribitylamino-2-amino-4,5-dimethylbenzene can be detected. When [1 degree -14C]riboflavin is used the 5,6-dimethylbenzimidazole contains about 75 per cent of the specific radioactivity of riboflavin. N-1-D-ribityl-amino-2-amino-4,5-dimethylbenzene is transformed into 5,6-dimethylbenzimidazole more efficiently than riboflavin. Oxygen enhances the yield of 5,6-dimethylbenzimidazole and 1,2-diamino-4,5-dimethylbenzene from riboflavin as well as from N-1-D-ribitylamino-2-amino-4,5-dimethylbenzene. 1,2-diamino-4,5-dimethylbenzene reacts together with formaldehyde but not with formate to form 5,6-dimethylbenzimidazole under alkaline conditions at 100 degrees C. It is therefore suggested that the nonenzymatic reaction of riboflavin proceeds via N-1-D-ribitylamino-2-amino-4,5-dimethylbenzene and 1,2-diamino-4,5-dimethylbenzene, and that the latter reacts with formaldehyde preferably formed by oxidative degradation of C-1 degree of the ribitly side chain to form 5,6-dimethylbenzimidazole via its unstable imidazoline derivative. The possible relevance of these results for the enzymatic process is discussed.
